HG146 for advanced adenoid cystic carcinoma
Part of Cancer clinical trials.
This trial tests a new drug called HG146 for people with advanced adenoid cystic carcinoma that has progressed despite previous treatments. The goal is to see if HG146 can slow or stop the cancer from growing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your adenoid cystic carcinoma must have come back or spread, and must have gotten worse in the past year.
- You must be in generally good health (able to perform daily activities without help).
- You must not have had any prior treatment with a drug that targets HDAC proteins.
- You must have at least one tumor that can be measured on a scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining the targeted drug becotatug vedotin with chemo can shrink recurrent adenoid cystic sinus tumors that can't be fully removed by surgery. It's for people whose tumors have a specific protein called EGFR.
This Phase 1/2 study tests how well CB-103 works in people with advanced, hard-to-treat adenoid cystic carcinoma that has a specific NOTCH pathway change. The study also looks at whether combining CB-103 with either lenvatinib or abemaciclib is safe and effective for different groups of patients.
This trial tests two medications given before surgery for advanced adenoid cystic carcinoma in the nose or sinuses. The goal is to shrink the tumor and make surgery safer and more effective.
This trial tests a new drug called APG-157 for people with advanced head and neck cancer that hasn't spread. It may be given before or instead of surgery, and the goal is to see if it helps shrink tumors or control the disease.
This trial tests a new drug, HS-20093, in people with advanced stomach or gastroesophageal junction cancer that has not responded to other treatments. The goal is to see if it can help shrink or slow the growth of the cancer.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
Hear when a new Adenoid Cystic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.